Key responsibilities:
- Lead the development and execution of global commercial external engagement strategy and associated tactical plans for Multiple Myeloma across all inline and lifecycle indications.
- Ensure enterprise collaboration (especially with medical affairs and R&D) to align on goals, strategies, tactics, and enabling insights to position GSK as a leader in Myeloma.
- Collaborate with medical and co-create markets to leverage and refine the Key External Expert (KEE) framework aligned to asset and therapy area strategy to develop and mobilize advocacy.
- Deliver high-quality, high-impact KEE engagement (e.g., Dots) and congress strategies/tactics through collaboration with internal and external stakeholders.
- Establish and track KPIs to measure commercial impact and inform rapid learning cycles.
- Coach and develop stakeholders and influence senior leaders to secure resources and alignment.
- As a member of the Global Commercial team, input into overarching asset and therapy area strategies.
- Ensure KEE engagement and congress strategies comply with relevant regulations and internal policies, maintaining high ethical standards.
Basic qualifications:
- Bachelorโs degree in business, life sciences, or related field.
- Minimum 10 yearsโ experience in the pharmaceutical or biotech industry.
- Demonstrated experience leading external engagement and congress strategies.
- Strong cross-functional collaboration skills in a matrix environment.
- Proven ability to use data and insights to inform strategic decisions and measure outcomes.
Preferred qualifications:
- Advanced degree (MBA, MPH, MSc, or related).
- Prior experience working in global launch in oncology or hematology.
- Commercial experience at the global or above-country (e.g., regional) level.
- Track record managing external agencies and vendor partnerships.
- Strong financial acumen (budget management and ROI assessments).
- Excellent communication and presentation skills for senior stakeholder engagement.